These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma. Williams SA; Gillan ER; Knoppel E; Buzby JS; Suen Y; Cairo MS Ann Oncol; 1997; 8 Suppl 1():25-30. PubMed ID: 9187425 [TBL] [Abstract][Full Text] [Related]
5. Improved intracellular delivery of oligonucleotides by square wave electroporation. Liu Y; Bergan R Antisense Nucleic Acid Drug Dev; 2001 Feb; 11(1):7-14. PubMed ID: 11258623 [TBL] [Abstract][Full Text] [Related]
6. Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progression. Stewart DA; Xu X; Thomas SD; Miller DM Nucleic Acids Res; 2002 Jun; 30(11):2565-74. PubMed ID: 12034846 [TBL] [Abstract][Full Text] [Related]
7. Modulation of cellular functions in retroorbital fibroblasts using antisense oligonucleotides targeting the c-myc protooncogene. Heufelder AE; Bahn RS Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1420-32. PubMed ID: 7775120 [TBL] [Abstract][Full Text] [Related]
8. Cationic lipids reduce time and dose of c-myc antisense oligodeoxynucleotides required to specifically inhibit Burkitt's lymphoma cell growth. Williams SA; Chang L; Buzby JS; Suen Y; Cairo MS Leukemia; 1996 Dec; 10(12):1980-9. PubMed ID: 8946941 [TBL] [Abstract][Full Text] [Related]
9. Psoralen-modified clamp-forming antisense oligonucleotides reduce cellular c-Myc protein expression and B16-F0 proliferation. Stewart DA; Thomas SD; Mayfield CA; Miller DM Nucleic Acids Res; 2001 Oct; 29(19):4052-61. PubMed ID: 11574688 [TBL] [Abstract][Full Text] [Related]
10. Electroporation of synthetic oligodeoxynucleotides: a novel technique for ex vivo bone marrow purging. Bergan R; Hakim F; Schwartz GN; Kyle E; Cepada R; Szabo JM; Fowler D; Gress R; Neckers L Blood; 1996 Jul; 88(2):731-41. PubMed ID: 8695822 [TBL] [Abstract][Full Text] [Related]
11. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice. Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406 [TBL] [Abstract][Full Text] [Related]
12. Programmable fusogenic vesicles for intracellular delivery of antisense oligodeoxynucleotides: enhanced cellular uptake and biological effects. Hu Q; Shew CR; Bally MB; Madden TD Biochim Biophys Acta; 2001 Sep; 1514(1):1-13. PubMed ID: 11513800 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration. Biro S; Fu YM; Yu ZX; Epstein SE Proc Natl Acad Sci U S A; 1993 Jan; 90(2):654-8. PubMed ID: 8421701 [TBL] [Abstract][Full Text] [Related]
14. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells. Ginobbi P; Geiser TA; Ombres D; Citro G Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627 [TBL] [Abstract][Full Text] [Related]
15. Transdermal transport of DNA antisense oligonucleotides by electroporation. Zewert TE; Pliquett UF; Langer R; Weaver JC Biochem Biophys Res Commun; 1995 Jul; 212(2):286-92. PubMed ID: 7626040 [TBL] [Abstract][Full Text] [Related]
16. Calcium dependent cellular uptake of a c-myc antisense oligonucleotide. Wu-Pong S; Weiss TL; Hunt CA Cell Mol Biol (Noisy-le-grand); 1994 Sep; 40(6):843-50. PubMed ID: 7812192 [TBL] [Abstract][Full Text] [Related]
17. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin. Leonetti C; Biroccio A; Candiloro A; Citro G; Fornari C; Mottolese M; Del Bufalo D; Zupi G Clin Cancer Res; 1999 Sep; 5(9):2588-95. PubMed ID: 10499637 [TBL] [Abstract][Full Text] [Related]
18. Uptake and efflux of intact antisense phosphorothioate deoxyoligonucleotide directed against angiotensin receptors in bovine adrenal cells. Li B; Hughes JA; Phillips MI Neurochem Int; 1997 Sep; 31(3):393-403. PubMed ID: 9246681 [TBL] [Abstract][Full Text] [Related]